Recent advances in allogeneic transplantation for acute myeloid leukemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in allogeneic transplantation for acute myeloid leukemia
Authors
Keywords
-
Journal
CURRENT OPINION IN ONCOLOGY
Volume 35, Issue 6, Pages 564-573
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-12
DOI
10.1097/cco.0000000000000992
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Posttransplant MRD and T-cell chimerism status predict outcomes in patients allografted with AML/MDS
- (2023) Justin Loke et al. Blood Advances
- Posttransplant Cyclophosphamide for Prevention of Graft-versus-Host Disease: The Prospective Randomized HOVON-96 Trial
- (2022) Annoek E.C. Broers et al. Blood Advances
- Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020—Report from World Marrow Donor Association
- (2022) Monique M. Jöris et al. BONE MARROW TRANSPLANTATION
- HLA-Matching with PTCy: A Reanalysis of a CIBMTR Dataset with Propensity Score Matching and Donor Age
- (2022) Alexander Joseph Ambinder et al. Blood Advances
- Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel
- (2022) Hartmut Döhner et al. BLOOD
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data
- (2022) Daniel A. Arber et al. BLOOD
- Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
- (2022) Lorenzo Lazzari et al. BONE MARROW TRANSPLANTATION
- Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
- (2022) Semra Aydin et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
- (2022) Madlen Jentzsch et al. Blood Cancer Journal
- Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years
- (2021) Jakob R. Passweg et al. BONE MARROW TRANSPLANTATION
- New challenges, new opportunities: Next generation sequencing and its place in the advancement of HLA typing
- (2021) Valia Bravo-Egana et al. HUMAN IMMUNOLOGY
- Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study
- (2021) Rui Zhang et al. Cancer Medicine
- Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
- (2021) Michael Heuser et al. Blood Advances
- Belumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study
- (2021) Corey S Cutler et al. BLOOD
- Omidubicel Versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized Study
- (2021) Mitchell E Horwitz et al. BLOOD
- Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
- (2021) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
- (2021) Michael Heuser et al. BLOOD
- Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
- (2021) Christoph Schmid et al. BONE MARROW TRANSPLANTATION
- Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
- (2021) Leo Luznik et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial
- (2021) Robert Zeiser et al. Lancet Haematology
- Molecular MRD status and outcome after transplantation in NPM1-mutated AML
- (2020) Richard Dillon et al. BLOOD
- Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
- (2020) Alexandros Spyridonidis et al. BONE MARROW TRANSPLANTATION
- FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
- (2020) Ahmad I. Antar et al. LEUKEMIA
- Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
- (2020) Robert P. Hasserjian et al. BLOOD
- Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors
- (2020) Juan Montoro et al. BONE MARROW TRANSPLANTATION
- Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
- (2020) Jaime Sanz et al. Journal of Hematology & Oncology
- Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
- (2020) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)
- (2020) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Double unrelated umbilical cord blood versus HLA-haploidentical bone marrow transplantation (BMT CTN 1101)
- (2020) Ephraim J Fuchs et al. BLOOD
- Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia
- (2020) Charles Craddock et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial
- (2020) Lei Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
- (2020) Juliet N. Barker et al. Blood Advances
- Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
- (2019) Javier Bolaños-Meade et al. Lancet Haematology
- Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia
- (2019) Xiao-Ning Gao et al. ANNALS OF HEMATOLOGY
- Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
- (2019) Thierry Guillaume et al. BONE MARROW TRANSPLANTATION
- Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update
- (2019) Giorgia Battipaglia et al. Clinical Lymphoma Myeloma & Leukemia
- Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
- (2019) Leonardo Javier Arcuri et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation
- (2019) Piyanuch Kongtim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Measurable Residual Disease Monitoring in Acute Myeloid Leukemia with t(8;21)(q22;q22.1): Results of the AML Study Group
- (2019) Frank G. Rücker et al. BLOOD
- Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia
- (2019) Yunju Ma et al. BONE MARROW TRANSPLANTATION
- Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies
- (2019) Jaime Sanz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- One and Half Million Hematopoietic Stem Cell Transplants (HSCT). Dissemination, Trends and Potential to Improve Activity By Telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT)
- (2019) Dietger Niederwieser et al. BLOOD
- Tolerability and efficacy of treatment with azacytidine as prophylactic or pre-emptive therapy for myeloid neoplasms after allogeneic stem cell transplantation
- (2019) Carolina Marini et al. Clinical Lymphoma Myeloma & Leukemia
- Next‐generation sequencing for measurable residual disease detection in acute myeloid leukaemia
- (2019) Jack Ghannam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
- (2019) Christopher S. Hourigan et al. JOURNAL OF CLINICAL ONCOLOGY
- Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
- (2019) Dietrich Wilhelm Beelen et al. Lancet Haematology
- Measurable residual disease, conditioning regimen intensity and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: a registry analysis of 2292 patients by the Acute Leukemia Working Party Eu
- (2018) Maria H Gilleece et al. AMERICAN JOURNAL OF HEMATOLOGY
- CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
- (2018) Marcos de Lima et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
- (2018) Annalisa Ruggeri et al. Journal of Hematology & Oncology
- Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
- (2018) Mohamed A. Kharfan-Dabaja et al. JAMA Oncology
- Measurable residual disease (MRD) monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
- (2018) Felicitas Thol et al. BLOOD
- Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome
- (2018) Piyanuch Kongtim et al. BONE MARROW TRANSPLANTATION
- Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or myelodysplastic syndrome
- (2018) Roman M. Shapiro et al. CURRENT OPINION IN HEMATOLOGY
- Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
- (2018) Richard F. Schlenk et al. BLOOD
- Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
- (2018) Christoph Schmid et al. BRITISH JOURNAL OF HAEMATOLOGY
- Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
- (2018) Uwe Platzbecker et al. LANCET ONCOLOGY
- Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
- (2017) Christoph Schmid et al. HAEMATOLOGICA
- Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
- (2017) Sarah A. Buckley et al. HAEMATOLOGICA
- Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
- (2017) Bart L. Scott et al. JOURNAL OF CLINICAL ONCOLOGY
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
- (2017) Christoph Schmid et al. HAEMATOLOGICA
- Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
- (2017) Sarah A. Buckley et al. HAEMATOLOGICA
- Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia
- (2016) Celalettin Ustun et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic Hematopoietic Stem Cell Transplantation in FLT3 -ITD–Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-Transplantation
- (2016) Gary J. Schiller et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
- (2016) P Tsirigotis et al. BONE MARROW TRANSPLANTATION
- Haematopoietic cell transplantation with and without sorafenib maintenance for patients withFLT3-ITD acute myeloid leukaemia in first complete remission
- (2016) Andrew M. Brunner et al. BRITISH JOURNAL OF HAEMATOLOGY
- Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia
- (2016) Farhad Ravandi et al. CANCER
- Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis
- (2016) Abhinav Deol et al. CANCER
- Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia
- (2016) Betül Oran et al. HAEMATOLOGICA
- Assessment of Minimal Residual Disease in Standard-Risk AML
- (2016) Adam Ivey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT
- (2016) Li Xuan et al. Oncotarget
- Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia
- (2016) Betül Oran et al. HAEMATOLOGICA
- Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation
- (2015) A. Tschan-Plessl et al. ANNALS OF HEMATOLOGY
- Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- (2015) Iskra Pusic et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
- (2015) Z Jedlickova et al. BONE MARROW TRANSPLANTATION
- Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation
- (2015) Ahmad Antar et al. Clinical Lymphoma Myeloma & Leukemia
- Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome
- (2015) Seunghoon Han et al. Journal of Hematology & Oncology
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia
- (2014) Yi-Bin Chen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
- (2014) P. Armand et al. BLOOD
- Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia
- (2014) Gaku Oshikawa et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation
- (2014) Mohamed L. Sorror et al. JOURNAL OF CLINICAL ONCOLOGY
- HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
- (2014) Loren Gragert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
- (2012) O. C. Goodyear et al. BLOOD
- A disease risk index for patients undergoing allogeneic stem cell transplantation
- (2012) P. Armand et al. BLOOD
- Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis
- (2012) Salut Brunet et al. JOURNAL OF CLINICAL ONCOLOGY
- High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
- (2012) S K Metzelder et al. LEUKEMIA
- Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
- (2012) Raynier Devillier et al. LEUKEMIA & LYMPHOMA
- Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib
- (2011) Manish Sharma et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
- (2011) C. Schmid et al. BLOOD
- FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo
- (2011) T. Sato et al. BLOOD
- Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
- (2011) Roland B. Walter et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
- (2011) U Platzbecker et al. LEUKEMIA
- Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
- (2010) V. Gupta et al. BLOOD
- Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome
- (2010) Marcos de Lima et al. CANCER
- 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
- (2009) A Czibere et al. BONE MARROW TRANSPLANTATION
- Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia
- (2009) Elias Jabbour et al. CANCER
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More